Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
Condition(s):Clostridium Difficile Infection; Solid Organ TransplantLast Updated:August 29, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Clostridium Difficile Infection; Solid Organ TransplantLast Updated:August 29, 2018Withdrawn
Condition(s):Non-melanoma Skin Cancer; Carcinoma, Squamous Cell; Carcinoma, Basal Cell; Keratinocyte CarcinomaLast Updated:September 26, 2023Recruiting
Condition(s):Immunocompromised Host; Organ Transplantation; CancerLast Updated:April 28, 2020Completed
Condition(s):Hepatitis C; Kidney Transplant; Complications; Heart Transplant InfectionLast Updated:March 12, 2024Recruiting
Condition(s):Cytomegalovirus Infections; Solid Organ TransplantLast Updated:February 20, 2024Terminated
Condition(s):Complications of Transplanted Organs and TissueLast Updated:December 9, 2020Completed
Condition(s):Organ Transplantation; Transplantation ImmunologyLast Updated:September 8, 2023Recruiting
Condition(s):Cardiovascular Disease; Acute Rejection of Cardiac Transplant; Cardiac Transplant Rejection; Heart Transplant Failure and RejectionLast Updated:March 26, 2021Completed
Condition(s):SARS-CoV-2Last Updated:September 13, 2023Completed
Condition(s):Cytomegalovirus ViraemiaLast Updated:August 2, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.